Valion Bio, Inc. Common Stock
VBIOStock
$0.53
Market Cap$1.71M
P/E—
Div yield—
Beta3.47
Price Chart
Favorite Metrics
Price vs S&P 500 (4W)-39.54%
VGM Score44.22
Market Capitalization$1.71M
Industry Peers — Electromedical Equipment(32)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
VBIOValion Bio, Inc. Common Stock | — | B | F | $0.53 |
| MDTMedtronic plc | B | C | C | $80.63 |
| MASIMasimo Corporation | D | D | B | $179.95 |
| LIVNLivaNova PLC Ordinary Shares | C | C | B | $78.68 |
| ITGRInteger Holdings Corporation | B | C | C | $89.54 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | $73.83 |
| AXGNAxogen, Inc. Common Stock | F | B | A | $44.69 |
| BLFSBioLife Solutions Inc. | F | B | B | $24.79 |
| CNMDCONMED Corporation | A | C | D | $33.80 |
| INMDInMode Ltd. Ordinary Shares | A | D | C | $13.35 |
| CBLLCeriBell, Inc. Common Stock | D | A | C | $18.39 |
About
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.